Delivery Order SPE2DB22D2007-SPE2DB24FH8AW

Award Date 12/20/23
Potential Completion Date 12/21/23
Potential Value $2.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,091.66 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of Timolol 0.5% Gel-Solution 5ML, a prescription eye medication. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract has a completion date of January 23, 2024. No set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,147.89, is for the delivery of TIMOLOL 0.25% GEL-SOLUTION 5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,021.26 firm fixed-price delivery order is for the supply of TIMOLOL 0.5% GEL-SOLUTION 5ML, a medication used to treat glaucoma. The contract has an ultimate completion date of March 12, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Timolol 0.5% Gel-Solution 5mL. The delivery order, valued at $15,888.80, is issued against an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that enables Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,577.13 contract is for the supply of TIMOLOL 0.5% GEL-SOLUTION 5ML, a prescription medication, with a performance period extending to May 27, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Timolol 0.5% Gel-Solution 5ML. The contract has a potential value of $3,080.77 and a period of performance through January 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with a potential value of up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Timolol 0.5% gel-solution, a pharmaceutical product used for the treatment of glaucoma. The contract has a ceiling value of $2,026.35 and a completion date of March 27, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of Timolol 0.5% Gel-Solution in 5mL vials, with a ceiling value of $2,000.70 and a performance period ending on September 16, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor responsible for delivering the requested medical product...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Timolol 0.5% Gel-Solution 5ml, a pharmaceutical product used to treat eye conditions. The Delivery Order has a ceiling value of $1,366.16 and an ultimate completion date of December 5, 2023. The contract is a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award is for the delivery of TIMOLOL 0.5% GEL-SOLUTION 5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,402.46 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 16, 2024. The contract has a completion date of December 17, 2024 and is a Firm Fixed Price Delivery Order. The contract is not associated with a set-aside. Amerisourcebergen Drug Corp holds a significant...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FH8AW
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of TIMOLOL 0.5% GEL-SOLUTION 5ML, a pharmaceutical product, with a potential value of $2,124.18. The contract is a firm fixed price, delivery order type, with a completion date of December 21, 2023. No set-aside designation was used. AmerisourceBergen Drug Corp has a history of providing pharmaceutical products and medical supplies to support DLA Troop Support Medical facilities and programs. The parent company, Cencora, Inc., operates under the DBA name of AmerisourceBergen.

Generated 3/20/24, 6:02 PM